ProKidney Corp (PROK) Wheel Strategy

Running a PROK wheel strategy lets you generate consistent premium income on ProKidney Corp while setting your own entry and exit prices on the underlying. ProKidney Corp's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own PROK, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best PROK wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on PROK, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable PROK wheel from a losing one.

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the PROK wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your PROK wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.